Asked by: Baroness Hayter of Kentish Town (Labour - Life peer)
Question to the Department for Transport:
To ask His Majesty's Government what timeline they have set for implementing changes to the fixed penalty for uninsured driving following the conclusion on 31 March 2026 of the consultation on proposed changes to penalties for motoring offences.
Answered by Lord Hendy of Richmond Hill - Minister of State (Department for Transport)
Once the Motoring Offences Consultation concludes, any changes the Government brings forward will be set out in the response.
The timelines for bringing forward any changes, including on the fixed penalty for uninsured driving, will then depend on legislative time.
Asked by: Baroness Hayter of Kentish Town (Labour - Life peer)
Question to the Department for Transport:
To ask His Majesty's Government what assessment they have made of the impact of non-compliant number plates on the ability to trace and prosecute hit-and-run drivers.
Answered by Lord Hendy of Richmond Hill - Minister of State (Department for Transport)
Under the new Road Safety Strategy, the Government has announced firm action to tackle non-compliant or ‘ghost’ numberplates. This includes consulting on tougher penalties, including penalty points and vehicle seizure, more robust checks on number plate suppliers, and higher industry standards for numberplates. We also intend to commission targeted research to explore the potential use of AI to identify illegal plates.
Asked by: Baroness Hayter of Kentish Town (Labour - Life peer)
Question to the Ministry of Housing, Communities and Local Government:
To ask His Majesty's Government when they plan to introduce legislation to require all property managing agents to be suitably qualified.
Answered by Baroness Taylor of Stevenage - Baroness in Waiting (HM Household) (Whip)
The government is committed to ensuring that those living in the rented and leasehold sectors are protected from abuse and poor service at the hands of unscrupulous property agents.
Property agents must already belong to a government-approved redress scheme. This legislative requirement is currently enforced by local authorities and National Trading Standards’ Lettings and Estate Agency Team, who have the power to issue warnings and banning orders to rogue estate and letting agents.
The redress schemes publish data on the number of complaints they receive, the amount awarded to consumers, and maintain a public list of agents that have been expelled from their respective schemes.
Managing agents play a key role in the maintenance of multi-occupancy buildings and freehold estates. Their importance will only increase as we transition toward a commonhold future, and so we are looking again at Lord Best’s 2019 report on regulating the property agent sector, particularly in light of the recommendations in the final Grenfell Inquiry report.
Many leaseholders face persistent delays and high costs when trying to sell their properties. Currently, freeholders and managing agents are responsible for providing essential sales information, but they often have little incentive to do so efficiently. Homeowners living on private or mixed tenure estates, who contribute to the maintenance and upkeep of communal areas, can face similar challenges when trying to obtain relevant information from their estate manager. The government will take forward measures in the Leasehold and Freehold Reform Act 2024 (LFRA) which will speed up the provision of information for leaseholders and homeowners on private or mixed tenure estates who wish to sell their property, and protect sellers from unreasonable fees when requesting this information.
The previous government committed to regulate the property agent sector in 2018 and asked a working group Chaired by Lord Best to advise them how to do it, yet it failed to respond to their findings from 2019. Managing agents play a key role in the maintenance of multi-occupancy buildings and freehold estates, and their importance will only increase as we transition toward a commonhold future, and so we are looking again at Lord Best’s 2019 report on regulating the property agent sector, particularly in light of the recommendations in the final Grenfell Inquiry report.
On 4 July 2025, we launched a wide-ranging consultation on proposals to hold landlords and managing agents to account for the services they provide and the charges and fees they levy. This included the introduction of mandatory qualifications for managing agents and estate managers on freehold estates. This consultation closed on 26 September 2025, and we are analysing responses.
On 6 October 2025, the government announced the biggest shake-up to home buying in this country’s history, including proposing a future consultation on mandatory qualifications for estate and letting agents. We also propose introducing a code of practice setting out the minimum standards expected of all residential property agents including estate, letting and managing agents.
We will set out our full position on regulation of estate, letting and managing agents in due course.
Asked by: Baroness Hayter of Kentish Town (Labour - Life peer)
Question to the Department for Education:
To ask His Majesty's Government what assessment they have made of the adequacy of school allergy-management policies.
Answered by Baroness Smith of Malvern - Minister of State (Department for Work and Pensions)
Section 100 of the Children and Families Act 2014 places a duty on maintained schools, academies and pupil referral units in England to make arrangements for supporting pupils with medical conditions. The accompanying statutory guidance makes clear to schools what is expected of them in taking reasonable steps to fulfil their legal obligations and to meet the individual needs of pupils with medical conditions, including allergies.
We intend to consult later this year on revised statutory guidance on ‘Supporting pupils at school with medical conditions’. This will seek views from schools, parents, health professionals, and other stakeholders on proposals to strengthen how schools meet their duties, including improvements to allergy safety and broader medical condition management. Our aim is to ensure that every child can access education safely and confidently, regardless of their health needs or allergy.
Asked by: Baroness Hayter of Kentish Town (Labour - Life peer)
Question to the Department for Business and Trade:
To ask His Majesty's Government what proportion of company directors successfully completed their identity verification with Companies House by the deadline of 18 November 2025; and whether feedback is being sought on the difficulties of completing the web-based verification process.
Answered by Baroness Lloyd of Effra - Baroness in Waiting (HM Household) (Whip)
Directors were not required to verify their identities by 18 November 2025. This date marked the start of a 12-month transition period during which existing directors must verify their identities by providing their personal code with the relevant companies' confirmation statement. This could only be done after the start of the transition period. The deadline for filing the confirmation statement determines the deadline for verification for existing directors. No significant decrease in the timeliness of confirmation statement filings has been observed.
Companies House continuously seeks feedback from its customers and is providing focussed support to those required to verify.
Asked by: Baroness Hayter of Kentish Town (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what discussions they have had with the General Medical Council about whether patients who ask for a doctor of a preferred sex will be told the biological sex or declared gender of that medical professional.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The General Medical Council (GMC) is the regulator of all medical doctors, physician assistants and physician assistants in anaesthesia, still legally known as anaesthesia associates and physician associates, practising in the United Kingdom. The GMC is independent of Government, directly accountable to Parliament and is responsible for operational matters concerning the discharge of its statutory duties.
The Government has had discussions with the GMC on this issue. The GMC’s Good Medical Practice states that professionals must act with honesty and integrity and ensure their conduct justifies patient’s trust in them and the public’s trust in the profession. They must also recognise a patient’s right to choose whether to accept their advice. It is up to individual healthcare providers, rather than the GMC, to consider patient requests for care based on sex.
Asked by: Baroness Hayter of Kentish Town (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what discussions they have had with the General Medical Council (GMC) about whether doctors are included on GMC registers by gender or biological sex.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The General Medical Council (GMC) is the regulator of all medical doctors, physician assistants and physician assistants in anaesthesia, still legally known as anaesthesia associates and physician associates, practising in the United Kingdom. The GMC is independent of Government, directly accountable to Parliament and is responsible for operational matters concerning the discharge of its statutory duties.
The GMC maintains the official register of registered medical practitioners. Under the Form and Content of the Register Regulations, the GMC records a doctor's gender rather than sex.
The Government has had some discussions with the GMC about this topic. In light of the Supreme Court ruling in the case of For Women Scotland v. The Scottish Ministers regarding the meaning of “sex” in the Equality Act 2010, the GMC is in the process of reviewing its policy position regarding the recording of a doctor’s gender or biological sex on its registers.
Asked by: Baroness Hayter of Kentish Town (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what assessment they have made of the public health risks posed by illegal online sales of optical appliances, particularly for children and other vulnerable groups.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for the regulation of medicines for human use, medical devices, and blood products for transfusion in the United Kingdom. This includes applying the legal controls on the retail sale, supply, and advertising of medicines which are set out in the Human Medicines Regulations 2012.
Sourcing medicines from unregulated suppliers significantly increases the risk of getting a product which is either falsified or not authorised for use. Products purchased in this way will not meet the MHRA’s strict quality and safety standards and could expose patients to incorrect dosages or dangerous ingredients.
Public safety is the number one priority for the MHRA, and its Criminal Enforcement Unit works hard to prevent, detect, and investigate illegal activity involving medicines and medical devices and takes robust enforcement action where necessary. It works closely with other health regulators, customs authorities, law enforcement agencies, and private sector partners, including e-commerce and the internet industry to identify, remove, and block online content promoting the illegal sale of medicines and medical devices.
The MHRA seeks to identify and, where appropriate, prosecute online sellers responsible for putting public health at risk. Last year, the MHRA and its partners seized more than 17 million doses of illegally traded medicines, including those usually issued on prescription. Additionally, the MHRA has also disrupted thousands of links to websites and social media pages selling medical products to the public illegally.
The MHRA’s FakeMeds campaign provides advice to people in the UK who are considering buying medication online, outlining how products can be accessed from safe and legitimate source.
Anyone who believes they’ve had a side effect from a medicine, or who believes they’ve received falsified stock, can report it to the MHRA’s Yellow Card scheme.
Asked by: Baroness Hayter of Kentish Town (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to ensure a level playing field for UK-based optometry practices and regulated optical business that provide compliant contact lens sales, in the light of unregulated overseas websites selling lenses in the UK.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The Medicines and Healthcare products Regulatory Agency (MHRA) ensures that medical devices placed on the market and put into service in the United Kingdom meet these regulatory requirements by:
- assessing all allegations of non-compliance brought to us, using a risk-based system;
- monitoring the activity of the UK approved bodies we designated to assess the compliance of manufacturers; and
- investigating medical devices as a result of adverse incident reports or intelligence indicating a potential problem.
If the MHRA considers a product to be breaching the medical devices regulations, typically, the MHRA’s Devices Compliance Unit will contact the manufacturer or, if the manufacturer is based outside of the UK, The UK Responsible Person, outlining our concerns and requesting further information with a view to bringing them into compliance.
If a manufacturer fails to co-operate with our requests and continues to place a non-compliant product on the market, or there is a serious risk to public health, the MHRA may consider using our enforcement powers. Guidance on how we enforce medical device regulations can be accessed on the GOV.UK website, in an online only format.
In addition to our investigatory and enforcement activities, the MHRA maintains ongoing relationships with external stakeholders, including other Government enforcement agencies and major online selling platforms to address non-compliant listings of medical devices available on the UK market, including those listed on overseas websites. This collaboration typically involves reporting mechanisms and proactive engagement with external online platforms to identify, address, and prevent non-compliant listings.
Asked by: Baroness Hayter of Kentish Town (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what plans they have to (1) extend regulatory powers, (2) improve reporting mechanisms, and (3) work with (a) online platforms, (b) manufacturers, (c) professional bodies, and (d) enforcement agencies, to address the illegal online sale of optical appliances.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring that medicines, medical devices, and blood components for transfusions on the market in the United Kingdom are safe, effective, and manufactured to the highest standards of quality. The Medical Devices Regulations 2002 (MDR 2002) establish the statutory framework that medical devices must meet in order to comply with these standards.
Optical appliances as medical devices must comply with the MDR 2002, which include bearing the UKCA or CE marking on the packaging or labelling of the device. Manufacturers or their UK representatives must also monitor the use of these devices when used in the UK and report serious incidents to the MHRA. Allegations of deficiencies and incidents that do not meet these standards must be reported to the MHRA through the Yellow card scheme or informed though published guidance around enforcement and compliance.